Treatment of dermatomyositis and sarcoidosis

The Treatment of Dermatomyositis and Sarcoidosis course provides a comprehensive understanding of these complex multisystem diseases, focusing on effective treatment strategies and holistic patient care. The program is structured into two detailed units:

Unit 1: Treatment of Dermatomyositis
This unit delves into the management of dermatomyositis, a condition with significant dermatological and systemic implications. Participants will explore diagnostic criteria, treatment pathways, and long-term management strategies.
Key topics include:
- Recognition of hallmark clinical features, including heliotrope rash, Gottron’s papules, and systemic muscle weakness.
- Initial treatment with prednisone and considerations for steroid-sparing medications.
- Long-term management strategies to mitigate risks associated with steroid use, such as osteoporosis prevention.
- Use of systemic agents like methotrexate, azathioprine, hydroxychloroquine, and biologics for severe or refractory cases.
This unit equips participants to manage dermatomyositis effectively, ensuring both symptom control and minimisation of long-term complications.

Unit 2: Treatment of Sarcoidosis
This unit focuses on sarcoidosis, a disease characterised by granulomatous inflammation affecting multiple organ systems. Participants will learn to navigate its cutaneous and systemic manifestations.
Key topics include:
- Comprehensive assessment of sarcoidosis, including lung, skin, and other organ involvement.
- Use of topical and systemic treatments such as corticosteroids, hydroxychloroquine, and methotrexate.
- Advanced management options for refractory cases, including infliximab and other biologics.
- Strategies to address disfigurement, systemic symptoms, and organ dysfunction.
This unit emphasises a multidisciplinary approach, highlighting the importance of collaboration with pulmonologists, rheumatologists, and dermatologists for optimal patient outcomes.

This course offers actionable insights and practical tools, empowering healthcare professionals to deliver personalised, effective care for patients with dermatomyositis and sarcoidosis. Participants will leave with the confidence to handle even the most challenging cases in these disease areas.